We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Calcium Carbonate Nanoparticles Stop Cancer by Neutralizing the Tumor Microenvironment

By LabMedica International staff writers
Posted on 17 Feb 2016
Print article
Image: Space-filling model of part of the crystal structure of calcium carbonate, CaCO3 (Photo courtesy of Wikimedia Commons).
Image: Space-filling model of part of the crystal structure of calcium carbonate, CaCO3 (Photo courtesy of Wikimedia Commons).
Tumor growth was halted in a mouse cancer model by the injection of novel calcium carbonate nanoparticles that neutralized the pH of the tumor microenvironment.

The acidic extracellular environment of tumors increases their aggressiveness and potential to metastasize, but few methods exist to selectively modulate the extracellular pH of the tumor environment. Transient flushing of biological systems with alkaline fluids or proton pump inhibitors is impractical and nonselective.

Investigators at Washington University (St. Louis, MO, USA) tried a new approach to modulate the pH of the tumor microenvironment. They used two processes, polyethyleneglycol-based diffusion and ethanol-assisted diffusion, to prepare calcium carbonate nanoparticles ranging in size from 20 to 300 microns. The nanoparticles were suspended in an albumin-based solvent that prevented aggregation and allowed them to be injected intravenously into an animal.

The investigators reported in the December 25, 2015, online edition of the journal Nanoscale that by using a mouse cancer model they were able to demonstrate that the selective accumulation of nano-calcium carbonate in tumors increased tumor pH over time, eventually reaching pH 7.4. Daily injections of calcium carbonate nanoparticles halted tumor growth in the mouse fibrosarcoma model, but stopping the injections allowed tumor growth to resume.

"Cancer kills because of metastasis," said Avik Som, a medical and doctoral student in biomedical engineering at Washington University. "The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH. Calcium and carbonate are both found heavily in the body, and they are generally non-toxic. When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones."

Related Links:

Washington University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.